The role of cell density and intratumoral heterogeneity in multidrug resistance
We conduct thorough medication reviews to identify potential drug interactions, especially for patients managing diabetes, hypertension, or hyperlipidemia, ensuring safe and effective treatment
What is established is that its pharmacokinetic profile supports once-weekly dosing, achieved through a C20 fatty diacid moiety that binds to serum albumin the same strategy used by semaglutide and tirzepatide, both of which have half-lives of approximately 5-7 days
Since 2022, the American Diabetes Association has updated its Standards of Care to recommend GLP1 receptor agonists as a firstline therapy for T2D 2 , eroding older and cheaper generics like metformin, which marks a momentous and fundamental change in treatment
Market Size and Growth The market size for GLP-1 drugs (including diabetes and obesity indications) is already in the tens of billions of dollars annually
